Recent research demonstrated a correlation between reduced SLC7A2 expression and an unfavorable prognosis in patients with ovarian cancer and hepatocellular carcinoma (HCC) [16, 17]. The gene discussed is SLC7A2; the disease is hepatocellular carcinoma.